Life Sciences

topic on 12 shows · 21 statements across 20 episodes

the Y Combinator Startup Podcast Innovators & Investors American Optimist Latent Space Lenny's Podcast No Priors Capital Allocators the MAD Podcast the a16z Podcast Big Technology All-In 20VC

21 statements about Life Sciences, every show

ALL-IN Assertion Not checkable as stated
Emanuel: China reached life sciences parity with the US within five years
“Massively invests in the life sciences, and within five years, China is not just nipping at our heels, the peripersu with the United States in life sciences. A place that the United States, outside of one or two examples in Europe, dominated.”
Rahm Emanuel Aug 12, 2026 ▶ 14:43 Rahm Emanuel: Trump's Foreign Policy, China, Europe's Decline, Immigration & DSA vs Democrats
Penn: AI in biology and life sciences is only at foot of exponential
“I think, you know, software engineering has been really transformed by AI. I think there's areas like biology, life sciences. These are all things that we're just kind of at like the foot of the exponential on. Like, maybe software engineering were on the expo…”
Dianne Penn Jul 26, 2026 ▶ 1:13:30 Why AI is going vertical (again) | Dianne Penn (Anthropic)
LATENT SPACE Prediction Not checkable as stated
Feinberg: Chipmakers will invest in life sciences as LLM alpha shrinks
“I do think that chip makers, including Nvidia, are going to want to get a lot more invested in life sciences because it will always be high in demand. And The amount of alpha left in pure LLM space is just getting a little questionable.”
Evan Feinberg Jun 30, 2026 ▶ 1:44:44 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Doronichev: Consumer AI models fall short for multi-million-dollar life science decisions
“Those are consumer grade AI systems that make a lot of our tasks easier, right? But when it comes to business and especially life sciences business applications, they often come short. Specifically there are special metrics in AI world, precision, recall hallu…”
Andrey Doronichev Apr 14, 2026 ▶ 1:37 Driving Efficiency in Biotech Research with Andrey Doronichev of BIOPTIC | The Innovators & Investors Podcast
BIG TECHNOLOGY Prediction Not checkable as stated
Levie: AI agents will increase life science experiments by 10x to 100x
“What we're gonna now be able to do is we will be able to run, you know, on the order of 10 to a hundred times more experiments across, you know, everything that we want to go detect.”
Aaron Levie Apr 8, 2026 ▶ 18:35 OpenAI vs. Anthropic's Direct Faceoff + Future of Agents — With Aaron Levie
a16z Prediction Not checkable as stated
Hsu: Near-term scientific research will rely on human-AI-robotics collaboration
“So what that might look like in the near term is collaboration between a scientist and a system that involves both an AI application and a robot and having that be a much more collaborative process in the near term In many different kinds of labs and many diff…”
Oliver Hsu Dec 31, 2025 ▶ 1:11 AI in 2026: 3 Predictions For What’s To Come (a16z Big Ideas)
a16z Prediction Not checkable as stated
Hsu: Autonomous labs will first penetrate mature markets like life sciences
“So I think there are certain categories of science where there is just a much more mature demand side market for the outputs of research. And examples include, of course, life sciences and pharma the chemicals industry facets of the material science industry. …”
Oliver Hsu Dec 31, 2025 ▶ 4:03 AI in 2026: 3 Predictions For What’s To Come (a16z Big Ideas)
NO PRIORS Prediction Not checkable as stated
Wickramasekara: AI will convert life sciences skeptics to structured data tools
“But now with like AI, one, I think the benefits are a much more immediately obvious to everyone. And so that's going to be this amazing tailwind to try to like do better here. And I think it will convince a lot of people who might have been skeptics in the pas…”
Sajith Wickramasekara Nov 13, 2025 ▶ 31:24 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
a16z Insight
Vance: Building physical world businesses is harder than digital media
“And they know that as hard as it is to build a business in digital media, it's still harder to build one in robotics or life sciences or energy in what we call the world of atoms.”
J.D. Vance Apr 23, 2025 ▶ 9:57 JD Vance on the Future of America
Matt Wood: Regulated industries are adopting GenAI faster due to existing data governance
“There is a group which is moving slightly faster than the average, which is somewhat Counterintuitive. And that group is actually the regulated industries. And so it's folks like in financial services and insurance and healthcare and life sciences and manufact…”
Matt Wood Jul 10, 2024 ▶ 2:21 Amazon's Longterm AI Vision — With AWS VP Matt Wood
Chinese competition threatens expected cyclical rebounds in semi equipment and life sciences
“I think where investors would be liable to get tripped up in these industries here is the snapback tends to be less sharp than expected because there's emerging competition from Chinese competitors.”
Sanjay Ayer Feb 5, 2024 ▶ 54:50 Sanjay Ayer – Think Different and Get Better at WCM (EP.366)
a16z Insight
Duffy: Rising Tech Fluency In Life Sciences Simplifies Building Healthtech Startups
“Today's cursive is JavaScript. So you're not it's not, so there's just more. Tech fluidity coming out of the, you know, I think the life sciences. Which speaks to more talent that can appreciate both worlds, which speaks to cultures that can build the best of …”
Sean Duffy Jan 4, 2024 ▶ 9:38 Fireside Chat with Sean Duffy
a16z Insight
Koller: ML lagged in life sciences due to lack of cross-disciplinary talent
“It wasn't having much of an impact in the life sciences, and I believe one of the main reasons for that is because there's so very few people who actually have the language of both disciplines and are able to bring them together.”
Daphne Koller Sep 25, 2023 ▶ 3:05 Digital Biology with insitro's Daphne Koller
NO PRIORS Insight
Koller: Tech workers entering biotech often disrespect biological challenges and create friction
“There's a lot of tech people who come in To life sciences, and it's like, we have that cell verbal. We are the smartest. We're machine learning. We're going to solve everything. And they don't respect the challenges of the other discipline. They sometimes don'…”
Daphne Koller May 19, 2023 ▶ 40:22 No Priors Ep. 6 | With Daphne Koller from Insitro
ALL-IN Insight
Friedberg: Intersection of AI/ML and life sciences creates massive opportunity
“I do think the intersection of life sciences with software creates this era of opportunity. It would probably be something in the realm of AIML meets life sciences, where you can actually work in a leveraged way with software to drive outcomes in these importa…”
David Friedberg Oct 14, 2022 ▶ 53:10 E100: Reflecting on the first 100 shows, fan questions, nuclear threat, markets, Amazon & more
CAPITAL ALLOCATORS Assertion Partly supported
O'Sullivan: SOSV is world's most active investor in life sciences and hardware
“We're the world's most active investor in life sciences and hardware and also just generally we would rank as Perhaps the world's third most active seed investor. And I think we make a top 10 in the world's most active Series A investors as well.”
Sean O'Sullivan Jan 17, 2022 ▶ 30:38 Sean O'Sullivan – Start-up Development at SOSV, Venture is Eating the Investment World 3 (Capital Allocators, EP.231)
CAPITAL ALLOCATORS Prediction Not checkable as stated
Casdin: Life sciences can compound at a 20% CAGR over next decade
“And I still think very confidently that you can compound at a 20% Tager over the next decade while buckle up because it's going to be very volatile and it's not going to happen in a straight line.”
Eli Casdin Jul 15, 2021 ▶ 1:05:12 Eli Casdin – Casdin Capital (Manager Meetings, EP.02)
AMERICAN OPTIMIST Prediction Not checkable as stated
Klausner: Life sciences will drive the 21st century across all industries
“We're at what I think will be viewed as truly a revolutionary golden age in life sciences, which is going to have impacts on everything. Not only we think about it as health, but it's going to change how we think about manufacturing the environment chemistry. …”
Dr. Rick Klausner Jun 29, 2021 ▶ 1:02 Dr. Rick Klausner: Curing Cancer, Reprogramming Cells, and the Incredible Biotech Revolution · Joe Lonsdale
20VC Prediction Not checkable as stated
Deven Parekh predicts life sciences will see Moore's Law-style compounding growth
“And you can think about a category that I think is going to have the same type of growth over the next 10 to 20 years and has had the same type, if not more, Moore's law effects. It's life sciences, biotech, pharma.”
Deven Parekh May 17, 2021 ▶ 37:07 20VC: Insight Managing Director, Deven Parekh on The Current Funding Mania, Compression of Round Timelines, Fund Deployment Speeds Increasing & How To Think Through Price and Time Allocation Across the Portfolio
Levy: Startup advisors are essentially just investors seeking free equity
“Advisors are investors who want stock for free, and that's kind of how I think about it. Like, you know, people should invest, ideally, instead of advising for free shares, and I know this is in like a one size, but some situations, like I was saying it's appr…”
Jon Levy Aug 29, 2018 ▶ 40:31 Carolynn Levy And Panel (Jon Levy, Jason Kwon) - Startup Legal Mechanics · Y Combinator
MAD Assertion Not checkable as stated
Wickramasekara: Most Benchling employees have no background in life science
“Most of our team actually has no background in the live science at all.”
Sajith Wickramasekara Feb 3, 2017 ▶ 13:05 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.